Quantcast
Close Window
   
WELCOME ;0)
Hello,
Johnson And Toxin is the largest, most comprehensive web site dedicated to exposing and ending corruption at Johnson & Johnson and subsidiaries that allows known risky, as well as known harmful, products to reach our healthcare system.
 
This site surpassed a million page views in December of 2015 - less than four years online!
 
This work is 100% independent. I am NOT a victim, NOT a lawyer, NOT paid by anyone other than visitors to the site.
 
Emily.
HomeAbout

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

Welcome <3
Thank you very much for stopping in. This work is 100% independent, visitor funded. Raised $390 this month. (August 26, 2016 at 7 PM EDT)
 
Goal: $2,000
Actual: $ 740
NEED: $1,260
It would be a shame to see 4 1/2 years of work disappear from the internet. Please help keep this effort to expose the flood of harmful Johnson & Johnson products online. The life saved may be your own.
With every gift received, I send out an easy-to-use tip sheet of resources to use to investigate products BEFORE you use them to reduce your risk of becoming a victim.
 
All gifts are CONFIDENTIAL unless otherwise requested.
 
God Bless You and Yours and keep All safe,
Emily.
Use GiftBox below or PayPal to Email:
emily@johnsonandtoxin.com
$.00   
 
Johnson & Johnson Consumer Sales Continue to Drop, 2011 to 2013
Johnson & Johnson consumer goods sales continue to slide in 2013 due to boycotts, recalls and more carcinogens in baby care products.

Keywords: jnj, johnson and johnson, johnson & johnson, J&J, boycott, recall, baby, products
Date Created/Edited: 2013, May 12
 

Special Sections....
Mesh Files
Baby Powder (talc) Files
Risperdal Files
Levaquin Files
Xarelto Files
Hips Files
Letters to Shareholders
SEC Lawsuits Files

 
Recent Content....
Johnson & Johnson Victims at Risk of RE-Victimization (2016, August 22)
If you are currently a victim of a known harmful Johnson & Johnson subsidiary product and have high medical needs due to your injuries, you are at increased risk of becoming a victim of another known harmful Johnson & Johnson subsidiary product.
jnj, johnson and johnson, johnson & johnson, victim, mesh, hip, levaquin, risperdal
 
Wealthy Most at Risk for Harm by Johnson & Johnson and Subsidiary Products (2016, August 22)
If you make over $100,000 a year, you are far more likely than lower incomes to become a victim of a Johnson & Johnson and/or subsidiary product.
healthcare, cost, co-pay, risk, deductable, insurance, victim, salary
 
Second Quarter 2016 Lawsuits Against Johnson & Johnson Leap Again From 82,200 to 90,700 (2016, August 4)
Growing every quarter, lawsuits against Johnson & Johnson in United States alone are now well over 90,700.
talc, risperdal, asr, hip, baby powder, tvt, mesh, lawsuit
 
Johnson & Johnson Animas Defective Diabetes Devices (2016, August 4)
Gosh and golly gee willikers, yet another Johnson & Johnson subsidiary, Animas, totally sucks, jah?
Johnson and Johnson, Johnson & Johnson, animas, vibe, diabetes, insulin, device, pump
 
Johnson & Johnson Ethicrap, I Mean EthiCON, More JNJ JUNK (2016, July 25)
As I've mentioned, Johnson & Johnson has so many bad products I have to put a bunch in each article now to try to keep up. Now for EthiCON crap.
Johnson and Johnson, Johnson & Johnson, ethicon, harmonic ace, morcellator, physiomesh, secure strap, stapler
 
Johnson and Johnson Janssen Xarelto Slaughter (2016, July 8)
Overstating benefits, downplaying (or not disclosing) risks. Xarelto by Johnson and Johnson Janssen killing people left and right. Over 500 DEAD, 7,100 lawsuits already. Lovely, eh?
false, marketing, death, dead, xarelto, FDA, lawsuit, Janssen
 
This Convinced THREE Juries That Johnson and Johnson Talc Increases Ovarian Cancer (2016, May 14)
One very simple fact convinced THREE juries that Johnson & Johnson talc increases risk of developing ovarian cancer.
Johnson and Johnson, Johnson & Johnson, baby, powder, cancer, lawsuit, ovarian, talc
 
First Quarter 2016 Lawsuits Against Johnson & Johnson Leap Again From 76,400 to 82,200 (2016, May 13)
Growing every quarter, lawsuits against Johnson & Johnson in United States alone are now well over 82,200.
levaquin, risperdal, asr, hip, transvaginal, tvt, mesh, lawsuit
 
Johnson & Johnson Lost THIRD Talc Ovarian Cancer Lawsuit (2016, May 10)
Although Johnson & Johnson marketing managers are sticking with the same mantra, talc is safe, Johnson & Johnson has already LOST THREE lawsuits against them for ovarian cancer caused by their talc powder and tried to bribe a victim.
Johnson and Johnson, Johnson & Johnson, baby, powder, cancer, lawsuit, 55 million, sued
 
2016 Consumer Letter to Johnson & Johnson Shareholders (2016, April 28)
Here we go with another Johnson and Johnson Annual Bullshitting of the Shareholders. I have a list of questions shareholders should consider asking Johnson & Johnson executives. (Post-meeting comments added.)
johnson and johnson, jnj, j&j, 2016, annual, shareholder, meeting, letter
 
2016 Johnson and Johnson US Lawsuit Update: Jump from 56,500 to 76,400 (2016, March 29)
Yet another year of a dramatic increase in lawsuits against Johnson & Johnson and subsidiaries in a lot of countries over a variety of products, and don't include many products with legal action pending.
levaquin, risperdal, asr, hip, transvaginal, tvt, mesh, lawsuit
 
Johnson & Johnson Lost Talc Powder Lawsuits TWICE and Offered to BRIBE Victim (2016, March 10)
Although Johnson & Johnson marketing managers are sticking with the same mantra, talc is safe, Johnson & Johnson has already LOST two lawsuits against them for ovarian cancer caused by their talc powder and tried to bribe a victim.
Johnson and Johnson, Johnson & Johnson, baby, powder, cancer, lawsuit, 72 million, sued
 
New United States Food and Drug Commissioner Dr. Robert Califf Responsible for KILLER Xarelto (2016, March 2)
As another likely corrupt FDA Commissioner, Dr. Margaret Hamburg, leaves, another likely corrupt FDA Commissioner, Dr. Robert Califf, appointed. Oh joy.
xarelto, FDA, commissioner, risk, johnson & johnson, johnson and johnson, bayer, califf
 
Up Next: Johnson & Johnson Baby Powder Talc Ovarian Cancer Lawsuits (2016, February 23)
After the goverment of India discovered Johnson & Johnson was using a banned method of sterlizating talc because it leaves a residue known to increase risk of ovarian cancer, women in US start the next round of US lawsuits against Johnson & Johnson: Baby Powder, ROUND ONE: JNJ LOST $72 MILLION! Wooo Hooo!
Johnson and Johnson, Johnson & Johnson, baby, powder, cancer, lawsuit, 72 million, sued
 
Why US Senate HELP Committee MUST SHUT DOWN Johnson & Johnson (2016, February 9)
As yet another FDA director is exposed for massive corruption, helping hide risks of JNJ killer drug Levaquin, it's time to shut down and re-evaluate ALL JNJ and 250 subsidiary products for safety.
fda, corruption, help committee, johnson & johnson, jnj, j&j, director, Margaret Hamburg
 
Asthma Rates Reduce After Toxic Chems Removed from Baby Products (2016,January 3)
Twenty years of activism truly paying off. With known harmful ingredients removed from Johnson & Johnson baby 'care' products, childhood asthma rates starting to decline.
asthma, cure, cause, johnson & johnson, product, infant, child, baby
 
Alexander Law Group, LLP Wins $70 Million Punitive Judgment Against Johnson & Johnson Subsidiary Ethicon Endo-Surgery (2015,December 14)
$9.8 Million in Compensatory Damages Levied by Jury Last Week
johnson & johnson, JNJ, j&j, ethicon, hemorrhoid, stapler, endo, defective
 
Numerous groups have called for boycotts of Johnson & Johnson products for a variety of reasons. In addition, as more mothers in the United States are educated regarding known carcinogens in the U.S. formulation of baby soap, shampoo, powder, lotions, creams and other baby products as well as the same carcinogens in adult care products, it is obvious that the sales of J&J toxic consumer products are suffering as consumers choose less toxic products.
 
2011 : 2011 consumer sales : U.S. decrease 6.7% / Int increase 7.3 / WW increase 2.0%
http://www.investor.jnj.com/2011annualreport/pdf/JNJ-2011_ManagementsDiscussion_AnalysisSales.pdf page 2 of 11
 
2012 : 1st quarter consumer sales : U.S. decrease 2.2% / Int decrease 2.5% / WW decrease 2.4%
Worldwide Consumer sales of $3.6 billion for the first quarter represented a decrease of 2.4% versus the prior year consisting of an operational decline of 0.6% and a negative impact from currency of 1.8%. Domestic sales decreased 2.2%. International sales decreased 2.5%, which reflected an operational increase of 0.4% and a negative currency impact of 2.9%.
http://www.jnj.com/connect/news/all/johnson-and-johnson-reports-2012-first-quarter-results
 
2012 : 2nd quarter consumer sales : U.S. decrease 1.9% / Int decrease 6.0% / WW decrease 4.6%
Worldwide Consumer sales of $3.6 billion for the second quarter represented a decrease of 4.6% versus the prior year consisting of an operational increase of 0.6% and a negative impact from currency of 5.2%. Domestic sales decreased 1.9%. International sales decreased 6.0%, which reflected an operational increase of 2.0% and a negative currency impact of 8.0%.
http://www.jnj.com/connect/news/all/johnson-and-johnson-reports-2012-second-quarter-results
 

2012 : 3rd quarter consumer sales : U.S. decrease 4.3% / Int decrease 6.1% / WW decrease 4.3%
Worldwide Consumer sales of $3.6 billion for the third quarter represented a decrease of 4.3% versus the prior year consisting of an operational increase of 1.0% and a negative impact from currency of 5.3%. Domestic sales decreased 0.4%. International sales decreased 6.1%, which reflected an operational increase of 1.8% and a negative currency impact of 7.9%.
http://www.jnj.com/connect/news/all/johnson-and-johnson-reports-2012-third-quarter-results
 
2012 : full year consumer sales : U.S. decrease 2% / Int decrease 3.4% / WW decrease 2.9%
Worldwide Consumer sales of $14.4 billion for the full-year 2012 represented a decrease of 2.9% versus the prior year, consisting of an operational increase of 0.5% and a negative impact from currency of 3.4%. Domestic sales decreased 2.0%; international sales decreased 3.4%, which reflected an operational increase of 1.9% and a negative currency impact of 5.3%.
http://www.jnj.com/connect/news/all/johnson-and-johnson-reports-2012-fourth-quarter-and-full-year-results
 
With yet another recall of Children's Tylenol and yet another undisclosed carcinogen found in yet another baby care product, I don't see Johnson & Johnson consumer sales rebounding any time soon. I don't know, maybe people don't want to risk using products on their children that might harm their precious babies. As people like me continue sharing the risks as fast as we can with other moms so they don't use toxic products, I think sales will likely continue to drop.
 
Something to consider: As fewer people use toxic products from Johnson & Johnson, the rate of long-term illnesses, such as asthma, allergies, chronic sinus infections, COPD, cancer, low fertility, and such, caused by these products (and the drugs prescribed to deal with side effects of the drugs prescribed) will begin to decline - cutting into Johnson & Johnson medical devices and pharmaceuticals sales ;o)
 
Resources:
1. Elizabeth Lopatto (2013, May 3). J&J Recalls Some Children’s Tylenol in South Korea Bloomberg. Retrieved from http://www.bloomberg.com/news/2013-05-03/j-j-recalls-some-children-s-tylenol-in-south-korea.html
 
2. Ganesh N (2013, April 25). FDA suspends J&J Licence New indian Express. Retrieved from http://www.newindianexpress.com/nation/FDA-suspends-JJ-Licence/2013/04/25/article1560077.ece
 
 
 
 
 
 
 
 
 
All contents Copyright © 2012-2016 Emily Patterson / Johnson and Toxin. All rights reserved.
 
Web Site and Admin Info:
Home
About
Contact
Disclaimers
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

 
Recently Posted:
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500
 
Johnson & Johnson Plans to Expand Healthcare Cost Crisis and Product Liability in Asia
 
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
 
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
 
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
 
Johnson & Johnson: The Global Lawsuit Company


 
 
Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
 
Johnson & Johnson Credo Analysis
 
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries